Loading...
XNAS
WALD
Market cap274mUSD
Dec 04, Last price  
2.43USD
1D
-0.82%
1Q
36.52%
IPO
-75.33%
Name

Waldencast PLC

Chart & Performance

D1W1MN
XNAS:WALD chart
P/E
P/S
1.00
EPS
Div Yield, %
Shrs. gr., 5y
Rev. gr., 5y
%
Revenues
274m
+25.55%
94,428,000142,472,000166,133,000218,138,000273,868,000
Net income
-42m
L-52.83%
-2,370,000-19,576,000-116,624,000-89,981,000-42,443,000
CFO
-9m
L-70.38%
-7,431,0003,529,000-85,014,000-29,775,000-8,820,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Waldencast Acquisition Corp. a skin care company, provides advanced skin care treatments. Its products are designed to help minimize the appearance of premature skin aging, skin damage, hyperpigmentation, acne, and sun damage primarily available through dermatologists, plastic surgeons, medical spas, and other skin care professionals. Its portfolio includes Obagi Medical that provides transformational skin care products formulated to minimize signs of skin aging, address dark spots, hyperpigmentation, fine lines, and wrinkles and to protect and enhance skin tone and texture; and Obagi Clinical that offers skin care products designed to prevent the early signs of skin aging. The company was founded in 1988 and is based in White Plains, New York.
IPO date
Mar 18, 2021
Employees
Domiciled in
US
Incorporated in
KY

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT